Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment process because our research has shown that the elite investors' consensus returns have been exceptional. In the following paragraphs, we find out what the billionaire investors and hedge funds think of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT). Is Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) a buy here? Money managers are taking a pessimistic view. The number of bullish hedge fund positions shrunk by 6 in recent months.